Skip to content

Measurement of Cerebral Oxygenation Using NIRS Method in the Preterm Infants With Intracranial Haemorrhagia

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01266889
Enrollment
20
Registered
2010-12-24
Start date
2010-12-31
Completion date
2011-05-31
Last updated
2010-12-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral Oxygenation, Intracranial Haemorrhagia

Keywords

preterm infant,cerebral oxygenation, intracranial haemorrhagia

Brief summary

The aim of the study was investigated the cerebral tissue oxygenation index (c-TOI) measured by near infrared spectroscopy (NIRS)in the preterm infants with intracranial haemorrhagia.

Interventions

DEVICEdevice:INVOS 5100

Continuous wave NIRS is a method for measurement of cerebral oxygenation and haemodynamics. This method is non-invasive, continuous, and can also be used as bedside monitoring. With continuous wave NIRS only changes in concentration of oxyhaemoglobin (O2Hb) and deoxyhaemoglobin (HHb) can be measured, not the absolute level of these parameters. It has been shown that changes in concentration of HbD (O2Hb - HHb) reflect changes in CBF. So, continuous monitoring of changes in concentration of HbD can be used as an indicator of changes in CBF, but changes in CBV will also influence the HbD signal, as will changes in arterial O2 saturation (saO2) and changes in cerebral metabolic rate for oxygen.

Sponsors

Zekai Tahir Burak Women's Health Research and Education Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
1 Days to 3 Days
Healthy volunteers
No

Inclusion criteria

.\<34 gestation week preterm infants with intracranial haemorrhagia

Exclusion criteria

* sepsis * NEC * congenital abnormalities * hydrocephalus * intracranial infections

Design outcomes

Primary

MeasureTime frame
cerebral oxygenation6 months

Countries

Turkey (Türkiye)

Contacts

Primary Contactugur dilmen, proff
ugurdilmen@gmail.com+90 312 506 5270

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026